Skip to main navigation Skip to search Skip to main content

Combination therapy of recurrent prostate cancer with the proteasome inhibitor bortezomib plus hormone blockade

  • Andrew S. Kraft
  • , Elizabeth Garrett-Mayer
  • , Amy E. Wahlquist
  • , Ali Golshayan
  • , Chien Shing Chen
  • , William Butler
  • , James Bearden
  • , Michael Lilly
  • MUSC
  • Medical University of South Carolina
  • Loma Linda University Cancer Center
  • South Carolina Oncology Associates
  • Gibbs Cancer Center and Research Institute
  • University of California, Irvine

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)119-124
Number of pages6
JournalCancer Biology and Therapy
Volume12
Issue number2
DOIs
StatePublished - Jul 15 2011

ASJC Scopus Subject Areas

  • Molecular Medicine
  • Oncology
  • Pharmacology
  • Cancer Research

Keywords

  • Bortezomib
  • Combination therapy
  • Hormone blockade
  • Neurotoxicity
  • Prostate specific antigen
  • Recurrent prostate cancer

Cite this